ArticleScientific reports2021

Basiliximab impairs regulatory T cell (TREG) function and could affect the short-term graft acceptance in children with heart transplantation.

Jacobo López-Abente et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.